In a report released yesterday, Conor McNamara from RBC Capital maintained a Hold rating on Hologic (HOLX – Research Report), with a ...

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $451.00. The company’s shares closed ...

Masco (NYSE:MAS) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

RBC Capital Markets believes the U.S. election could serve as a key clearing moment for stocks, with positive effects on the ...

What analysts expect? RBC Capital Markets continues to see Palantir’s (PLTR) valuation as “unsustainable” absent a ...

The expansion is likely to lead to a state of oversupply by the end of 2026, analysts such as RBC’s Anan Dhanani have ...

ConocoPhillips is exploring a sale of some of its shale operations in the Permian Basin worth more than $1 billion, two years ...

RBC Capital lowered the firm’s price target on Magna (MGA) to $42 from $47 and keeps a Sector Perform rating on the shares as ...

CoStar Group (CSGP) was trading lower after RBC Capital Markets downgraded the real estate services provider on declined ...

RBC Capital raised the firm’s price target on ResMed (RMD) to $232 from $224 and keeps a Sector Perform rating on the shares. The company reported a strong Q1 result with double digit revenue ...

RBC Capital initiated coverage of StandardAero (SARO) with an Outperform rating and $37 price target StandardAero is the largest independent engine maintenance, repair and overhaul provider ...